Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health www.cancer.gov

Navigation

Personal tools

You are here: Home / Sites / H. Lee Moffitt Cancer Center / Munoz-Antonia, Teresita

Munoz-Antonia, Teresita (Ph.D.)

Investigator, H. Lee Moffitt Cancer Center, (813) 979-3884

Contact Information

Email: mailto:antoniat@moffitt.usf.edu
Fax: (813) 979-3893
Co-Principal Investigator
TGF-beta, Smads

To update contact information, please visit the Data Management and Coordinating Center.

Open Protocols

Protocol Name Biomarkers Datasets
Biomarker Dev Lab At Moffitt Supplement 0 0
Protocol for Comparing Promoter Hypermethylation Methods in NSCLC 0 0
The Biomarker Knowledge System Informatics Pilot Project Supplement To The Biomarker Development Laboratory at Moffitt (Bedlam) 0 0
The Early Detection Research Network: Biomarker Reference Laboratories 0 0

Closed Protocols

Protocol Name Biomarkers Datasets
EDRN Resource Network Exchange 0 0
Standard Specimen Reference Set: Lung 0 0

Publications

Publication Name PubMed ID Journal
Microsatellite instability at AAAG repeat sequences in respiratory tract cancers. 11146445 Int. J. Cancer
A systematic review and lessons learned from early lung cancer detection trials using low-dose computed tomography of the chest. 12915809 Cancer Control
Lung cancer evolution to preinvasive management. 11901918 Clin. Chest Med.
Data mining techniques for cancer detection using serum proteomic profiling. 15364092 Artif Intell Med
Polymorphisms for microsomal epoxide hydrolase and genetic susceptibility to COPD. 15702235 Int. J. Mol. Med.
Moving to the routine management of pre symptomatic lung cancer. 11720735 Lung Cancer
Genetic analysis of microsomal epoxide hydrolase gene and its association with lung cancer risk. 15901990 Eur. J. Cancer Prev.
Loss of heterogeneous ribonucleoprotein A(2)/B(1) expression in thyroid neoplasms. 11421561 Endocr Pract
The human 8-oxoguanine DNA N-glycosylase 1 (hOGG1) DNA repair enzyme and its association with lung cancer risk. 15077011 Pharmacogenetics
Defective transforming growth factor beta signaling pathway in head and neck squamous cell carcinoma as evidenced by the lack of expression of activated Smad2. 11410498 Clin. Cancer Res.
Transforming growth factor-beta type II receptors and smad proteins in follicular thyroid tumors. 10942134 Laryngoscope
Transforming growth factor beta receptors in verrucous and squamous cell carcinoma. 10448730 Arch. Otolaryngol. Head Neck Surg.
Expression of transforming growth factor beta type II receptors in head and neck squamous cell carcinoma. 10389906 Clin. Cancer Res.
Transforming growth factor beta receptors and p27kip in thyroid carcinoma. 9932593 Arch. Otolaryngol. Head Neck Surg.
Evaluating serial observations of precancerous lesions for further study as a trigger for early intervention. 12210622 Stat Med
Discovery of distinct protein profiles specific for lung tumors and pre-malignant lung lesions by SELDI mass spectrometry. 12781425 Lung Cancer
Screening for lung cancer with CT: a preliminary cost-effectiveness analysis. 12006436 Chest
Diagnosis of roentgenographically occult lung cancer by sputum cytology. 11901920 Clin. Chest Med.
Consensus statements from the Second International Lung Cancer Molecular Biomarkers Workshop: a European strategy for developing lung cancer molecular diagnostics in high risk populations. 12118333 Int. J. Oncol.
Polymorphisms of the DNA repair gene XRCC1 and lung cancer risk. 11219768 Cancer Epidemiol. Biomarkers Prev.
Considerations in developing successful, population-based molecular screening and prevention of lung cancer. 11147628 Cancer
Efficacy of two sputum collection techniques in patients with air flow obstruction. 10432886 Acta Cytol.
Advances in sputum analysis for screening and early detection of lung cancer. 10740657 Cancer Control
The early detection of occult lung cancer. 11091923 Chest Surg. Clin. N. Am.
Expression of early lung cancer detection marker: hnRNP-A2/B1 and its relation to microsatellite alteration in non-small cell lung cancer. 11714531 Lung Cancer
Lung cancer: chemoprevention and intermediate effect markers. 11220665 IARC Sci. Publ.

To update protocols, publications, biomarkers, or science data, please contact the Informatics Center.

Addresses

12902 Magnolia Dr., MRC 3 West
H. Lee Moffitt Cancer Center

To update addresses, please visit the Data Management and Coordinating Center.

Announcement



EDRN Founder Honored

Dr. Sudhir Srivastava was honored with the Distinguished Service Award from the American Pancreatic Association at the group's annual meeting this year, for his outstanding commitment to pancreatology.